Vincent R. Anicetti is COO at Coherus BioSciences, Inc. (CHRS). They have made 12 open-market trades across 1 company since 2019, most recently 2021-07-06.
CIK 0001733375
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CHRS | 124,790 | $126K |
Shares reported on the most recent Form 4, priced at the 2021-07-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CHRS | SELL | 2021-03-05 | 2021-03-09 | $15.46 | $824K | -5.1% | -13.3% | -15.7% |
| CHRS | SELL · 10b5-1 | 2021-02-17 | 2021-02-19 | $17.45 | $43K | -10.0% | -7.8% | -20.2% |
| CHRS | SELL · 10b5-1 | 2021-01-19 | 2021-01-21 | $17.94 | $45K | -2.8% | -8.4% | -17.4% |
| CHRS | SELL · 10b5-1 | 2020-12-17 | 2020-12-21 | $17.51 | $44K | -1.1% | +7.1% | -7.5% |
| CHRS | SELL | 2020-12-07 | 2020-12-09 | $18.42 | $324K | -5.0% | +0.4% | -11.0% |
| CHRS | SELL | 2020-12-03 | 2020-12-07 | $18.76 | $3.7M | -2.1% | -5.2% | -12.1% |
| CHRS | SELL | 2020-11-17 | 2020-11-19 | $17.70 | $686K | +5.8% | -3.3% | -2.8% |
| CHRS | SELL | 2020-10-19 | 2020-10-21 | $17.89 | $115K | +0.6% | +10.2% | +9.3% |
| CHRS | SELL | 2020-09-17 | 2020-09-21 | $18.84 | $94K | -5.9% | -13.8% | -10.4% |
| CHRS | SELL | 2020-08-17 | 2020-08-19 | $19.37 | $97K | -4.1% | +0.7% | -10.1% |
| CHRS | SELL | 2020-07-17 | 2020-07-21 | $18.25 | $274K | -6.2% | +3.7% | -9.0% |
| CHRS | SELL · 10b5-1 | 2020-06-17 | 2020-06-19 | $17.22 | $43K | +7.4% | +10.6% | +12.2% |
| CHRS | SELL · 10b5-1 | 2020-05-18 | 2020-05-20 | $17.17 | $53K | +11.8% | +1.0% | +13.8% |
| CHRS | SELL | 2020-04-17 | 2020-04-21 | $16.30 | $165K | -3.0% | -1.6% | +13.9% |
| CHRS | SELL | 2020-02-18 | 2020-02-20 | $21.64 | $162K | -12.8% | -36.6% | -23.1% |
| CHRS | SELL | 2020-01-17 | 2020-01-22 | $19.60 | $196K | -0.8% | +19.4% | -14.0% |
| CHRS | SELL · 10b5-1 | 2019-12-16 | 2019-12-18 | $18.69 | $47K | +0.1% | +6.5% | -25.6% |
| CHRS | SELL · 10b5-1 | 2019-11-14 | 2019-11-18 | $19.26 | $48K | -5.8% | -5.9% | +16.0% |
| CHRS | SELL · 10b5-1 | 2019-10-14 | 2019-10-16 | $18.40 | $46K | -9.5% | +1.9% | +6.9% |
| CHRS | SELL | 2019-09-16 | 2019-09-18 | $20.03 | $50K | -1.6% | -6.4% | -9.8% |
| CHRS | SELL · 10b5-1 | 2019-08-14 | 2019-08-16 | $19.00 | $48K | +15.2% | +8.9% | -0.3% |
| CHRS | SELL · 10b5-1 | 2019-07-15 | 2019-07-17 | $19.20 | $48K | -8.1% | +6.5% | +6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.